首页> 美国卫生研究院文献>Cell Transplantation >Enhanced Neurogenesis and Collaterogenesis by Sodium Danshensu TreatmentAfter Focal Cerebral Ischemia in Mice
【2h】

Enhanced Neurogenesis and Collaterogenesis by Sodium Danshensu TreatmentAfter Focal Cerebral Ischemia in Mice

机译:丹参素钠增强神经发生和胶原生成小鼠局灶性脑缺血后

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ischemic stroke remains a serious threat to human life. There are limited effectivetherapies for the treatment of stroke. We have previously demonstrated that angiogenesisand neurogenesis in the brain play an important role in functional recovery followingischemic stroke. Recent studies indicate that increased arteriogenesis and collateralcirculation are determining factors for restoring reperfusion and outcomes of strokepatients. Danshensu, the root extract, is used intreatments of various human ischemic events in traditional Chinese medicine. Itstherapeutic mechanism, however, is not well clarified. Due to its proposed effect onangiogenesis and arteriogenesis, we hypothesized that danshensu could benefit strokerecovery through stimulating neurogenesis and collaterogenesis in the post-ischemia brain.Focal ischemic stroke targeting the right sensorimotor cortex was induced in wild-typeC57BL6 mice and transgenic mice expressing green fluorescent protein (GFP) to label smoothmuscle cells of brain arteries. Sodium danshensu (SDS, 700 mg/kg) was administeredintraperitoneally (i.p.) 10 min after stroke and once daily until animals were sacrificed.To label proliferating cells, 5-bromo-2′-deoxyuridine (BrdU; 50 mg/kg, i.p.) wasadministered, starting on day 3 after ischemia and continued once daily until sacrifice.At 14 days after stroke, SDS significantly increased the expression of vascularendothelial growth factor (VEGF), stromal-derived factor-1 (SDF-1), brain-derivedneurotrophic factor (BDNF), and endothelial nitric oxide synthase (eNOS) in theperi-infarct region. SDS-treated animals showed increased number of doublecortin(DCX)-positive cells. Greater numbers of proliferating endothelial cells and smooth musclecells were detected in SDS-treated mice 21 days after stroke in comparison with vehiclecontrols. The number of newly formed neurons labeled by NeuN and BrdU antibodies increasedin SDS-treated mice 28 days after stroke. SDS significantly increased the newly formedarteries and the diameter of collateral arteries, leading to enhanced local cerebral bloodflow recovery after stroke. These results suggest that systemic sodium danshensu treatmentshows significant regenerative effects in the post-ischemic brain, which may benefitlong-term functional recovery from ischemic stroke.
机译:缺血性中风仍然是对人类生命的严重威胁。有效有限治疗中风的疗法。我们之前已经证明了血管生成脑中的神经元和神经发生在以下功能恢复中起重要作用缺血性中风。最近的研究表明,动脉生成和侧支增加循环是恢复再灌注和中风结果的决定因素耐心。根提取物丹参素用于中药对各种人类局部缺血事件的治疗。它的然而,治疗机理尚不清楚。由于拟议的影响血管生成和动脉生成,我们假设丹参素可能有益于中风通过刺激缺血后大脑中的神经发生和共生而恢复。野生型诱导针对右感觉运动皮层的局灶性缺血性中风表达绿色荧光蛋白(GFP)以平滑标记的C57BL6小鼠和转基因小鼠脑动脉的肌肉细胞。服用丹参素钠(SDS,700 mg / kg)中风后10分钟腹膜内(i.p.),每天一次直至处死动物。为了标记增殖细胞,使用了5-溴-2'-脱氧尿苷(BrdU; 50 mg / kg,腹膜内)。从缺血后第3天开始给药,每天持续一次直至处死。中风后14天,SDS显着增加了血管的表达内皮生长因子(VEGF),基质衍生因子1(SDF-1),脑源性神经营养因子(BDNF)和内皮一氧化氮合酶(eNOS)梗塞周围区域。经SDS处理的动物显示双皮质素数量增加(DCX)阳性细胞。大量增殖的内皮细胞和平滑肌与媒介物相比,中风后21天在SDS处理的小鼠中检测到细胞控件。 NeuN和BrdU抗体标记的新形成的神经元数量增加在中风后28天接受SDS处理的小鼠体内。 SDS大大增加了新成立的动脉和侧支动脉的直径,导致局部脑血流量增加中风后血流恢复。这些结果提示全身性丹参素钠治疗在缺血后的大脑中显示出显着的再生作用,这可能有益于缺血性卒中的长期功能恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号